Here are five key notes:
1. NuVasive anticipates revenue will reach around $811 million in 2015, a 6 percent increase over 2014. This is close to the $810 million the company previously issued as guidance for the full year.
2. In the fourth quarter, NuVasive anticipates reaching $215 million.
3. NuVasive expects the full year 2015 non-GAAP operating profit margin to exceed the previous financial performance guidance of around 15.2 percent.
4. NuVasive recently acquired Ellipse Technologies, driving company growth. Margin expansion is expected as the company reaches past $1 billion in revenue.
5. The Ellipse Technologies transaction is expected to close in February 2016 and NuVasive expects to update its full year and long-term financial performance guidance to reflect the acquisition.
More articles on orthopedic devices:
K2M 2015 preliminar revenue up 16%: 5 key notes
Tax on medical device company revenue suspended: 3 key points
Is your medical device hacked? 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
